President Joe Biden’s fiscal 2024 budget request is chock-full of proposals to further reduce drug prices, both administratively and legislatively, and while many are likely to hit a brick wall in the GOP-led House, they signal Democrats’ resolve to keep hitting hard against the pharmaceutical industry in the lead up to the next presidential election. In addition to expanding CMS’ new Medicare drug price negotiation and inflation rebate authorities, the budget proposes an $11 billion program to treat and prevent...